Latest filing published 03 May 2018 for DNA Oyj, €118.
No signal scores available.
All filings by Timo Karppinen on record concern DNA Oyj. In total, 4 filings cover trades dated from 1 December 2016 to 2 May 2018.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 3 May 2018 came the latest disclosure, a transaction for €118 in DNA Oyj. Typically, a trade is published a median of 3 days after it takes place. The regulation allows three business days to notify a trade (MAR article 19). Every figure here comes from the filings published by Nasdaq Helsinki and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations